[
  {
    "date": "2023-12-30",
    "symbol": "FULC",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "security12btitle": "Common stock, par value $0.001 per share",
    "tradingsymbol": "FULC",
    "securityexchangename": "NASDAQ",
    "entityregistrantname": "FULCRUM THERAPEUTICS, INC.",
    "entitycentralindexkey": 1680581,
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "entityshellcompany": "false",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityfilenumber": "001-38978",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "47-4839948",
    "entityaddressaddressline1": "26 Landsdowne Street",
    "entityaddresscityortown": "Cambridge",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2139,
    "cityareacode": 617,
    "localphonenumber": "651-8851",
    "documenttransitionreport": "false",
    "icfrauditorattestationflag": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "documentannualreport": "true",
    "entityvoluntaryfilers": "No",
    "entitywellknownseasonedissuer": "No",
    "auditorname": "Ernst & Young LLP",
    "auditorfirmid": 42,
    "auditorlocation": "Boston, Massachusetts",
    "cashandcashequivalentsatcarryingvalue": 25563000,
    "marketablesecurities": 210658000,
    "unbilledreceivablescurrent": 537000,
    "prepaidexpenseandotherassetscurrent": 5441000,
    "assetscurrent": 242199000,
    "propertyplantandequipmentnet": 5216000,
    "operatingleaserightofuseasset": 7176000,
    "restrictedcashnoncurrent": 1092000,
    "otherassetsnoncurrent": 2011000,
    "assets": 257694000,
    "accountspayablecurrent": 2757000,
    "accruedliabilitiesandothercurrentliabilities": 8726000,
    "operatingleaseliabilitycurrent": 2192000,
    "liabilitiescurrent": 13675000,
    "operatingleaseliabilitynoncurrent": 8629000,
    "otherliabilitiesnoncurrent": 197000,
    "liabilities": 22501000,
    "commonstockvalue": 62000,
    "additionalpaidincapitalcommonstock": 744940000,
    "accumulatedothercomprehensiveincomelossnetoftax": -136000,
    "retainedearningsaccumulateddeficit": -509673000,
    "stockholdersequity": 235193000,
    "liabilitiesandstockholdersequity": 257694000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 5000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 200000000,
    "commonstocksharesissued": 61915367,
    "commonstocksharesoutstanding": 61915367,
    "revenuefromcontractwithcustomerincludingassessedtax": 2805000,
    "researchanddevelopmentexpense": 71801000,
    "generalandadministrativeexpense": 41668000,
    "operatingexpenses": 113469000,
    "operatingincomeloss": -110664000,
    "interestincomeexpensenonoperatingnet": 13329000,
    "netincomeloss": -97335000,
    "earningspersharebasic": -1.59,
    "earningspersharediluted": -1.59,
    "weightedaveragenumberofdilutedsharesoutstanding": 61310,
    "weightedaveragenumberofsharesoutstandingbasic": 61310,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": 661000,
    "othercomprehensiveincomelossnetoftax": 661000,
    "comprehensiveincomenetoftax": -96674000,
    "sharesoutstanding": 61915367,
    "stockissuedduringperiodvaluenewissues": 10000,
    "stockissuedduringperiodsharesnewissues": 9615384,
    "stockissuedduringperiodvalueemployeebenefitplan": 777000,
    "stockissuedduringperiodsharesemployeebenefitplan": 182628,
    "stockissuedduringperiodsharesrestrictedstockawardgross": 18144,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 14802000,
    "profitloss": -97335000,
    "depreciation": 2172000,
    "sharebasedcompensation": 14802000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 5991000,
    "increasedecreaseinaccountsreceivable": 308000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 1072000,
    "increasedecreaseinoperatingleaseassetsandliabilities": 715000,
    "increasedecreaseinotheroperatingassets": -94000,
    "increasedecreaseinaccountspayable": -853000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": -825000,
    "increasedecreaseindeferredrevenue": -934000,
    "netcashprovidedbyusedinoperatingactivities": -90965000,
    "paymentstoacquiremarketablesecurities": 194892000,
    "proceedsfrommaturityofmarketablesecurities": 158708000,
    "paymentstoacquirepropertyplantandequipment": 508000,
    "netcashprovidedbyusedininvestingactivities": -36692000,
    "proceedsfromissuanceofcommonstockinconnectionwithfollowonoffering": 117345000,
    "proceedsfromissuanceofcommonstock": 777000,
    "netcashprovidedbyusedinfinancingactivities": 118122000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -9535000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 26655000,
    "cashpaidforoperatingleaseliabilities": 3333000,
    "propertyplantandequipmentusefullife": "P5Y",
    "propertyplantandequipmentusefullives": "Shorter of useful life or remaining lease term",
    "numberofoperatingsegments": 1,
    "cashandcashequivalentsfairvaluedisclosure": 25563000,
    "availableforsalesecuritiesdebtsecurities": 14215000,
    "assetsfairvaluedisclosure": 236221000,
    "cashandcashequivalentsamortizedcost": 25563000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 14229000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 10000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 24000,
    "cashequivalentsandmarketablesecuritiesamortizedcostbasis": 236357000,
    "cashequivalentsandmarketablesecuritiesaccumulatedgrossunrealizedgainsbeforetax": 131000,
    "cashequivalentsandmarketablesecuritiesaccumulatedgrossunrealizedlossbeforetax": 267000,
    "cashequivalentsandmarketablesecuritiesfairvaluedisclosure": 236221000,
    "aggregatefairvalueofsecuritiesremainingcontractualmaturityofgreaterthanoneyear": 25100000,
    "debtsecuritiesavailableforsalecontinuousunrealizedlosspositionlessthan12months": 130200000,
    "debtsecuritiesavailableforsalecontinuousunrealizedlosspositiongreaterthan12months": 33800000,
    "propertyplantandequipmentgross": 9682000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 12760000,
    "prepaidexpenses": 3658000,
    "prepaidsignonbonusessubjecttovestingprovisions": 71000,
    "interestreceivable": 1712000,
    "accruedresearchanddevelopmentexpenses": 3164000,
    "employeerelatedliabilitiescurrent": 4712000,
    "accruedprofessionalfeescurrent": 454000,
    "otherliabilitiescurrent": 396000,
    "commonstockvotingrights": "Each share of common stock entitles the holder to one vote on all matters submitted to a vote of the Company’s stockholders",
    "numberofcommonstockvotingrights": 1,
    "commonstockcapitalsharesreservedforfutureissuance": 9972217,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 4.64,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvaluevested": 100000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 30400000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y10M28D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 75017,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 37045,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 18144,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 10.77,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 12.59,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 9.79,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 9972217,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 6089933,
    "stockissuedduringperiodsharesstockoptionsexercised": 38903,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 2582893,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 3225146,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 8.44,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 5.87,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 8.96,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 11.33,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 12.59,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P7Y2M1D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 15114074,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 407817,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.037,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y1M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.986,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 20602,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 11.03,
    "nonrefundableupfrontpaymentsreceived": 10000000,
    "researchdevelopmentandsalesarrangementaggregateamountreceivableuponachievementofmilestone": 2500000,
    "revenuefromcontractwithcustomerexcludingassessedtax": 2800000,
    "reimbursementpaymentrecieved": 4900000,
    "unbilledaccountsreceivablerelatedtoreimbursableresearchanddevelopmentcost": 500000,
    "paymentforprepaidresearchfunding": 2500000,
    "stockissuedduringperiodsharespurchaseofassets": 12500000,
    "clinicalandregulatorymilestonepayables": 37500000,
    "clinicalandregulatorymilestonepayablesuponphasetwoclinicaltrial": 2500000,
    "salesmilestone": 60000000,
    "operatingleasesfutureminimumpaymentsduecurrent": 2572000,
    "operatingleasesfutureminimumpaymentsdueintwoyears": 2649000,
    "operatingleasesfutureminimumpaymentsdueinthreeyears": 2729000,
    "operatingleasesfutureminimumpaymentsdueinfouryears": 2811000,
    "thereafter": 1426000,
    "lesseeoperatingleaseliabilitypaymentsdue": 12187000,
    "lessimputedinterest": -1575000,
    "operatingleaseliability": 10612000,
    "variableleasepayment": 900000,
    "operatingleaseexpense": 1900000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationnondeductibleexpense": -0.0071,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.0147,
    "effectiveincometaxratereconciliationfederalorphandrugcredits": 0.0941,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.0592,
    "effectiveincometaxratereconciliationofficerscompensationpercent": -0.0106,
    "effectiveincometaxratereconciliationotherreconcilingitemspercent": -0.001,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.3593,
    "deferredtaxassetsoperatinglosscarryforwards": 75005000,
    "deferredtaxassetscapitalizedresearchanddevelopmentcosts": 16911000,
    "deferredtaxassetsorphandrugcreditcarryforwards": 14628000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 10140000,
    "deferredtaxassetsgoodwillandintangibleassets": 6918000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 5232000,
    "deferredtaxassetsoperatingleaseliability": 3613000,
    "deferredtaxassetsdeferredincome": 251000,
    "deferredtaxassetsgross": 132698000,
    "deferredtaxassetsvaluationallowance": 129512000,
    "deferredtaxassetsnet": 3186000,
    "deferredincometaxliabilities": 3186000,
    "operatinglosscarryforwardsvaluationallowance": 35000000,
    "operatinglosscarryforwards": 312300000,
    "operatinglosscarryforwardsexpirationyear": 2036,
    "operatinglosscarryforwardsindefinitely": 288700000,
    "taxcreditcarryforwardamount": 6000000,
    "taxcreditcarryforwardexpirationyear": 2040,
    "opentaxyear": "2016 2017 2018 2019 2020",
    "definedcontributionplanname": "401(k)",
    "definedcontributionplanemployerdiscretionarycontributionamount": 700000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 9972217
  },
  {
    "date": "2022-12-30",
    "symbol": "FULC",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "security12btitle": "Common stock, par value $0.001 per share",
    "tradingsymbol": "FULC",
    "securityexchangename": "Nasdaq Global Market",
    "entityregistrantname": "FULCRUM THERAPEUTICS, INC.",
    "entitycentralindexkey": 1680581,
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "currentfiscalyearenddate": "12-31",
    "entityfilercategory": "Non-accelerated filer",
    "entityshellcompany": "false",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "☐ ",
    "entityfilenumber": "001-38978",
    "entityincorporationstatecountrycode": "Delaware",
    "entitytaxidentificationnumber": "47-4839948",
    "entityaddressaddressline1": "26 Landsdowne Street",
    "entityaddresscityortown": "Cambridge",
    "entityaddressstateorprovince": "Massachusetts",
    "entityaddresspostalzipcode": 2139,
    "cityareacode": 617,
    "localphonenumber": "651-8851",
    "documenttransitionreport": "false",
    "icfrauditorattestationflag": "false",
    "documentannualreport": "true",
    "entityvoluntaryfilers": "No",
    "entitywellknownseasonedissuer": "No",
    "auditorname": "Ernst & Young LLP",
    "auditorfirmid": 42,
    "auditorlocation": "Boston, Massachusetts",
    "cashandcashequivalentsatcarryingvalue": 35098000,
    "marketablesecurities": 167823000,
    "unbilledreceivablescurrent": 229000,
    "prepaidexpenseandotherassetscurrent": 4369000,
    "assetscurrent": 207519000,
    "propertyplantandequipmentnet": 6906000,
    "operatingleaserightofuseasset": 10800000,
    "restrictedcashnoncurrent": 1092000,
    "otherassetsnoncurrent": 2105000,
    "assets": 226685000,
    "accountspayablecurrent": 3638000,
    "accruedliabilitiesandothercurrentliabilities": 9551000,
    "operatingleaseliabilitycurrent": 2200000,
    "deferredrevenuecurrent": 934000,
    "liabilitiescurrent": 16725000,
    "otherliabilitiesnoncurrent": 197000,
    "operatingleaseliabilitynoncurrent": 13400000,
    "liabilities": 27743000,
    "commonstockvalue": 52000,
    "additionalpaidincapitalcommonstock": 612025000,
    "accumulatedothercomprehensiveincomelossnetoftax": -797000,
    "retainedearningsaccumulateddeficit": -412338000,
    "stockholdersequity": -412338000,
    "liabilitiesandstockholdersequity": 226685000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "revenuefromcontractwithcustomerincludingassessedtax": 6342000,
    "researchanddevelopmentexpense": 76782000,
    "generalandadministrativeexpense": 41694000,
    "restructuringandrelatedcostincurredcost": 427000,
    "operatingexpenses": 118903000,
    "operatingincomeloss": -112561000,
    "interestincomeexpensenonoperatingnet": 2690000,
    "netincomeloss": -109871000,
    "earningspersharebasic": -2.44,
    "earningspersharediluted": -2.44,
    "weightedaveragenumberofdilutedsharesoutstanding": 44991,
    "weightedaveragenumberofsharesoutstandingbasic": 44991,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": -400000,
    "othercomprehensiveincomelossnetoftax": -400000,
    "comprehensiveincomenetoftax": -110271000,
    "sharesoutstanding": "null",
    "stockissuedduringperiodvaluenewissues": 80804000,
    "stockissuedduringperiodsharesnewissues": "null",
    "stockissuedduringperiodvalueemployeebenefitplan": 3519000,
    "stockissuedduringperiodsharesemployeebenefitplan": 433403,
    "stockissuedduringperiodvaluerestrictedstockawardgross": 1000,
    "stockissuedduringperiodsharesrestrictedstockawardgross": 76718,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 13350000,
    "profitloss": -109872000,
    "depreciation": 2414000,
    "sharebasedcompensation": 3698000,
    "accretionamortizationofdiscountsandpremiumsinvestments": -152000,
    "increasedecreaseinaccountsandotherreceivables": -2500000,
    "increasedecreaseinaccountsreceivable": -908000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 170000,
    "increasedecreaseinoperatingleaseassetsandliabilities": 372000,
    "increasedecreaseinotheroperatingassets": 1562000,
    "increasedecreaseinaccountspayable": -1176000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": 555000,
    "increasedecreaseindeferredrevenue": -3777000,
    "netcashprovidedbyusedinoperatingactivities": -97050000,
    "paymentstoacquiremarketablesecurities": 151153000,
    "proceedsfrommaturityofmarketablesecurities": 165529000,
    "paymentstoacquirepropertyplantandequipment": 1963000,
    "netcashprovidedbyusedininvestingactivities": 12413000,
    "proceedsfromissuanceofcommonstockinconnectionwithfollowonoffering": 80804000,
    "proceedsfromissuanceofcommonstock": 3519000,
    "netcashprovidedbyusedinfinancingactivities": 84323000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -314000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 36190000,
    "cashpaidforoperatingleaseliabilities": 2219000,
    "capitalexpendituresincurredbutnotyetpaid": 26000,
    "propertyplantandequipmentusefullife": 3,
    "propertyplantandequipmentestimatedusefullives": "Shorter of useful life or remaining lease term",
    "numberofoperatingsegments": 1,
    "cashandcashequivalentsfairvaluedisclosure": 35098000,
    "availableforsalesecuritiesdebtsecurities": 167823000,
    "assetsfairvaluedisclosure": 177747000,
    "cashandcashequivalentsamortizedcost": 35102000,
    "cashandcashequivalentsaccumulatedgrossunrealizedlossesbeforetax": -4000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 168616000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 3000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 796000,
    "cashequivalentsandmarketablesecuritiesamortizedcostbasis": 203718000,
    "cashequivalentsandmarketablesecuritiesaccumulatedgrossunrealizedgainsbeforetax": 3000,
    "cashequivalentsandmarketablesecuritiesaccumulatedgrossunrealizedlossbeforetax": -800000,
    "cashequivalentsandmarketablesecuritiesfairvaluedisclosure": 202921000,
    "aggregatefairvalueofsecuritiesremainingcontractualmaturityofgreaterthanoneyear": 37300000,
    "debtsecuritiesavailableforsalecontinuousunrealizedlosspositionlessthan12months": 111100000,
    "debtsecuritiesavailableforsalecontinuousunrealizedlosspositiongreaterthan12months": 42900000,
    "propertyplantandequipmentgross": 17568000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 10662000,
    "prepaidexpenses": 3425000,
    "prepaidsignonbonusessubjecttovestingprovisions": 92000,
    "interestreceivable": 852000,
    "accruedresearchanddevelopmentexpenses": 4700000,
    "employeerelatedliabilitiescurrent": 4211000,
    "accruedprofessionalfeescurrent": 535000,
    "otherliabilitiescurrent": 105000,
    "commonstockvotingrights": "Each share of common stock entitles the holder to one vote on all matters submitted to a vote of the Company’s stockholders",
    "numberofcommonstockvotingrights": 1,
    "commonstockcapitalsharesreservedforfutureissuance": "null",
    "sharesreservedforconversionofpreferredstockandfutureissuanceofcommonstock": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "four year",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 8.55,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 7.62,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 2600000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvaluevested": 200000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 32000000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.86,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 76718,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 126803,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 10174,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 9.73,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 10.09,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 3.35,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": "null",
    "stockissuedduringperiodsharesstockoptionsexercised": 381661,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 11.99,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 10.21,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 8.36,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 14.33,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 12.99,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 7.52,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 98187,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.027000000000000003,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 6.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 50085,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 10.65,
    "nonrefundableupfrontpaymentsreceived": 10000000,
    "researchdevelopmentandsalesarrangementaggregateamountreceivableuponachievementofmilestone": 2500000,
    "rangeoftieredroyaltiesonnetsales": "mid single-digit percentage to a low double-digit percentage",
    "revenuefromcontractwithcustomerexcludingassessedtax": 5300000,
    "deferredrevenue": 6700000,
    "cumulativecatchupadjustment": 1700000,
    "deferredrevenuecurrentandnoncurrent": 900000,
    "reimbursementpaymentrecieved": 5600000,
    "researchdevelopmentandsalesarrangementamountreceiveduponachievementofmilestone": 2000000,
    "unbilledaccountsreceivablerelatedtoreimbursableresearchanddevelopmentcost": 200000,
    "paymentforprepaidresearchfunding": 2500000,
    "stockissuedduringperiodsharespurchaseofassets": "null",
    "clinicalandregulatorymilestonepayables": 5000000,
    "clinicalandregulatorymilestonepayablesuponphasetwoclinicaltrial": 2500000,
    "salesmilestone": 60000000,
    "operatingleasesfutureminimumpaymentsduecurrent": 836000,
    "operatingleasesfutureminimumpaymentsdueintwoyears": 210000,
    "operatingleasesfutureminimumpaymentsdueinthreeyears": 2649000,
    "operatingleasesfutureminimumpaymentsdueinfouryears": 2729000,
    "thereafter": 4237000,
    "lesseeoperatingleaseliabilitypaymentsdue": 1046000,
    "lessimputedinterest": -29000,
    "operatingleaseliability": 1017000,
    "variableleasepayment": 1000000,
    "lesseeoperatingleaseremainingleaseterm": 1.2,
    "operatingleaseexpense": 700000,
    "lesseeoperatingleasediscountrate": 0.042,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationnondeductibleexpense": -0.0069,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.0144,
    "effectiveincometaxratereconciliationfederalorphandrugcredits": 0.0723,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.057800000000000004,
    "effectiveincometaxratereconciliationownershipchangepercent": -0.0292,
    "effectiveincometaxratereconciliationotherreconcilingitemspercent": -0.0013000000000000002,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.3171,
    "deferredtaxassetsoperatinglosscarryforwards": 75005000,
    "deferredtaxassetscapitalizedresearchanddevelopmentcosts": 16911000,
    "deferredtaxassetsorphandrugcreditcarryforwards": 14600000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 10140000,
    "deferredtaxassetsgoodwillandintangibleassets": 6918000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 5232000,
    "deferredtaxassetsoperatingleaseliability": 3613000,
    "deferredtaxassetsdeferredincome": 251000,
    "deferredtaxassetsgross": 132698000,
    "deferredtaxassetsvaluationallowance": 129512000,
    "deferredtaxassetsnet": 3186000,
    "deferredincometaxliabilities": 3186000,
    "operatinglosscarryforwardsvaluationallowance": 34900000,
    "operatinglosscarryforwards": 272600000,
    "operatinglosscarryforwardsexpirationyear": 2036,
    "operatinglosscarryforwardsindefinitely": 251500000,
    "taxcreditcarryforwardamount": 4000000,
    "taxcreditcarryforwardexpirationyear": 2030,
    "opentaxyear": "2016 2017 2018 2019 2020",
    "definedcontributionplanname": "401(k)",
    "definedcontributionplanemployerdiscretionarycontributionamount": 800000,
    "paymentsforoperatingactivities": 427000,
    "restructuringcharges": 400000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null"
  },
  {
    "date": "2021-12-30",
    "symbol": "FULC",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "security12btitle": "Common stock, par value $0.001 per share",
    "tradingsymbol": "FULC",
    "securityexchangename": "Nasdaq Global Market",
    "entityregistrantname": "FULCRUM THERAPEUTICS, INC.",
    "entitycentralindexkey": 1680581,
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "currentfiscalyearenddate": "12-31",
    "entityfilercategory": "Non-accelerated filer",
    "entityshellcompany": "false",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "☐ ",
    "entityfilenumber": "001-38978",
    "entityincorporationstatecountrycode": "Delaware",
    "entitytaxidentificationnumber": "47-4839948",
    "entityaddressaddressline1": "26 Landsdowne Street",
    "entityaddresscityortown": "Cambridge",
    "entityaddressstateorprovince": "Massachusetts",
    "entityaddresspostalzipcode": 2139,
    "cityareacode": 617,
    "localphonenumber": "651-8851",
    "documenttransitionreport": "false",
    "icfrauditorattestationflag": "false",
    "documentannualreport": "true",
    "entityvoluntaryfilers": "No",
    "entitywellknownseasonedissuer": "No",
    "auditorname": "Ernst & Young LLP",
    "auditorfirmid": 42,
    "auditorlocation": "Boston, Massachusetts",
    "cashandcashequivalentsatcarryingvalue": 35412000,
    "marketablesecurities": 182750000,
    "accountsreceivablegrosscurrent": 2500000,
    "unbilledreceivablescurrent": 1137000,
    "prepaidexpenseandotherassetscurrent": 4199000,
    "assetscurrent": 225998000,
    "propertyplantandequipmentnet": 7368000,
    "restrictedcashnoncurrent": 1092000,
    "otherassetsnoncurrent": 542000,
    "assets": 235000000,
    "accountspayablecurrent": 4788000,
    "accruedliabilitiesandothercurrentliabilities": 9231000,
    "leaseincentivepayablecurrent": 469000,
    "deferredrevenuecurrent": 4711000,
    "liabilitiescurrent": 19199000,
    "deferredrentcreditnoncurrent": 1680000,
    "leaseincentivepayablenoncurrent": 2582000,
    "liabilities": 23461000,
    "commonstockvalue": 41000,
    "additionalpaidincapitalcommonstock": 514362000,
    "accumulatedothercomprehensiveincomelossnetoftax": -397000,
    "retainedearningsaccumulateddeficit": -302467000,
    "stockholdersequity": -302467000,
    "liabilitiesandstockholdersequity": 235000000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "revenuefromcontractwithcustomerincludingassessedtax": 19163000,
    "researchanddevelopmentexpense": 69701000,
    "generalandadministrativeexpense": 30516000,
    "operatingexpenses": 100217000,
    "operatingincomeloss": -81054000,
    "interestincomeexpensenonoperatingnet": 207000,
    "netincomeloss": -80847000,
    "earningspersharebasicanddiluted": -2.29,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 35361,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": -395000,
    "othercomprehensiveincomelossnetoftax": -395000,
    "comprehensiveincomenetoftax": -81242000,
    "sharesoutstanding": "null",
    "stockissuedduringperiodvaluenewissues": 182857000,
    "stockissuedduringperiodsharesnewissues": 550000,
    "stockissuedduringperiodvalueemployeebenefitplan": 3668000,
    "stockissuedduringperiodsharesemployeebenefitplan": 381967,
    "stockissuedduringperiodvaluerestrictedstockawardgross": 5000,
    "stockissuedduringperiodsharesrestrictedstockawardgross": 112691,
    "stockrepurchasedduringperiodshares": 2971,
    "treasurystocksharesretired": 2971,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 11070000,
    "profitloss": -80847000,
    "depreciation": 2515000,
    "sharebasedcompensation": 4456000,
    "accretionamortizationofdiscountsandpremiumsinvestments": -673000,
    "increasedecreaseinaccountsandotherreceivables": 500000,
    "increasedecreaseinaccountsreceivable": 606000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 134000,
    "increasedecreaseinotheroperatingassets": -36000,
    "increasedecreaseinaccountspayable": 973000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": 1950000,
    "increasedecreaseindeferredrevenue": -13170000,
    "increasedecreaseindeferredrentanddeferredleaseincentive": -438000,
    "netcashprovidedbyusedinoperatingactivities": -78478000,
    "paymentstoacquiremarketablesecurities": 216234000,
    "proceedsfrommaturityofmarketablesecurities": 88278000,
    "paymentstoacquirepropertyplantandequipment": 1713000,
    "netcashprovidedbyusedininvestingactivities": -129669000,
    "proceedsfromissuanceofcommonstockinconnectionwithpublicofferingsnetofissuancecosts": 182857,
    "repaymentsoflongtermcapitalleaseobligations": 18000,
    "proceedsfromissuanceofcommonstock": 5700000,
    "netcashprovidedbyusedinfinancingactivities": 186507000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -21640000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 36504000,
    "capitalexpendituresincurredbutnotyetpaid": 37000,
    "paymentsofstockissuancecosts": 200000,
    "propertyplantandequipmentusefullife": 3,
    "propertyplantandequipmentestimatedusefullives": "Shorter of useful life or remaining lease term",
    "numberofoperatingsegments": 1,
    "cashandcashequivalentsfairvaluedisclosure": 35412000,
    "availableforsalesecuritiesdebtsecurities": 182750000,
    "assetsfairvaluedisclosure": 182750000,
    "cashandcashequivalentsamortizedcost": 35412000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 183147000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 397000,
    "cashequivalentsandmarketablesecuritiesamortizedcostbasis": 218559000,
    "cashequivalentsandmarketablesecuritiesaccumulatedgrossunrealizedlossbeforetax": 397000,
    "cashequivalentsandmarketablesecuritiesfairvaluedisclosure": 218162000,
    "aggregatefairvalueofsecuritiesremainingcontractualmaturityofgreaterthanoneyear": 39700000,
    "debtsecuritiesavailableforsalecontinuousunrealizedlosspositionlessthan12months": 180800000,
    "propertyplantandequipmentgross": 15637000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 8269000,
    "prepaidexpenses": 3400000,
    "prepaidsignonbonusessubjecttovestingprovisions": 326000,
    "interestreceivable": 473000,
    "accruedresearchanddevelopmentexpenses": 3171000,
    "employeerelatedliabilitiescurrent": 4990000,
    "accruedprofessionalfeescurrent": 996000,
    "otherliabilitiescurrent": 74000,
    "commonstockvotingrights": "Each share of common stock entitles the holder to one vote on all matters submitted to a vote of the Company’s stockholders",
    "numberofcommonstockvotingrights": 1,
    "commonstockcapitalsharesreservedforfutureissuance": 706658,
    "sharesreservedforconversionofpreferredstockandfutureissuanceofcommonstock": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "four year",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 8.57,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 11.37,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 3500000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvaluevested": 1500000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 34600000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.76,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 10174,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 42858,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsrepurchasedinperiod": 2971,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 3.35,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 2.94,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsrepurchasedinperiodweightedaveragegrantdatefairvalue": 3.22,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": "null",
    "stockissuedduringperiodsharesstockoptionsexercised": 341952,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 408708,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 13.91,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 15.56,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 9.74,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 12.44,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 11.54,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 7.7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.009000000000000001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 6.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.873,
    "nonrefundableupfrontpaymentsreceived": 10000000,
    "researchdevelopmentandsalesarrangementaggregateamountreceivableuponachievementofmilestone": 2500000,
    "rangeoftieredroyaltiesonnetsales": "mid single-digit percentage to a low double-digit percentage",
    "revenuefromcontractwithcustomerexcludingassessedtax": 9600000,
    "deferredrevenue": 6700000,
    "cumulativecatchupadjustment": 1700000,
    "accountsreceivablerelatedparties": 2500000,
    "deferredrevenuecurrentandnoncurrent": 4099999.9999999995,
    "reimbursementpaymentrecieved": 3200000,
    "researchdevelopmentandsalesarrangementamountreceiveduponachievementofmilestone": 2000000,
    "unbilledaccountsreceivablerelatedtoreimbursableresearchanddevelopmentcost": 500000,
    "stockissuedduringperiodsharespurchaseofassets": "null",
    "clinicalandregulatorymilestonepayables": 37500000,
    "salesmilestone": 60000000,
    "lesseeoperatingleaseoptiontoextend": "The Company has the option to extend the term of the lease for two successive one-year periods, at the market rate, by giving the landlord written notice of its election to exercise the extension at least nine months prior to the original expiration of the lease term.",
    "lesseeoperatingleaseliabilitypaymentsdue": 1659000,
    "leaseandrentalexpense": 100000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 613000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 836000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 210000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 2649000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 2729000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 4237000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationnondeductibleexpense": -0.0031,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.0239,
    "effectiveincometaxratereconciliationfederalorphandrugcredits": 0.0451,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.061200000000000004,
    "effectiveincometaxratereconciliationotherreconcilingitemspercent": -0.0006,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.33649999999999997,
    "deferredtaxassetsoperatinglosscarryforwards": 67043000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 8774000,
    "deferredtaxassetsorphandrugcreditcarryforwards": 6700000,
    "deferredtaxassetsgoodwillandintangibleassets": 6192000,
    "deferredtaxassetsdeferredincome": 1061000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 4537000,
    "deferredtaxassetsleaseincentive": 832000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsdeferredrent": 471000,
    "deferredtaxassetsgross": 95589000,
    "deferredtaxassetsvaluationallowance": 94630000,
    "deferredtaxassetsnet": 959000,
    "deferredincometaxliabilities": 959000,
    "operatinglosscarryforwardsvaluationallowance": 27200000,
    "operatinglosscarryforwards": 244000000,
    "operatinglosscarryforwardsexpirationyear": 2036,
    "operatinglosscarryforwardsindefinitely": 214800000,
    "taxcreditcarryforwardamount": 3300000,
    "taxcreditcarryforwardexpirationyear": 2030,
    "opentaxyear": "2016 2017 2018 2019 2020",
    "definedcontributionplanname": "401(k)",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null"
  },
  {
    "date": "2020-12-30",
    "symbol": "FULC",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2020-12-31",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "security12btitle": "Common stock, par value $0.001 per share",
    "tradingsymbol": "FULC",
    "securityexchangename": "NASDAQ",
    "entityregistrantname": "FULCRUM THERAPEUTICS, INC.",
    "entitycentralindexkey": 1680581,
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "entityshellcompany": "false",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityfilenumber": "001-38978",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "47-4839948",
    "entityaddressaddressline1": "26 Landsdowne Street",
    "entityaddresscityortown": "Cambridge",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2139,
    "cityareacode": 617,
    "localphonenumber": "651-8851",
    "documenttransitionreport": "false",
    "icfrauditorattestationflag": "false",
    "documentannualreport": "true",
    "entityvoluntaryfilers": "No",
    "entitywellknownseasonedissuer": "No",
    "cashandcashequivalentsatcarryingvalue": 57052000,
    "marketablesecurities": 55862000,
    "accountsreceivablegrosscurrent": 2000000,
    "unbilledreceivablescurrent": 531000,
    "prepaidexpenseandotherassetscurrent": 4065000,
    "assetscurrent": 119510000,
    "propertyplantandequipmentnet": 8397000,
    "restrictedcashnoncurrent": 1092000,
    "otherassetsnoncurrent": 578000,
    "assets": 129577000,
    "accountspayablecurrent": 4079000,
    "accruedliabilitiesandothercurrentliabilities": 7267000,
    "leaseincentivepayablecurrent": 469000,
    "deferredrevenuecurrent": 14910000,
    "liabilitiescurrent": 26725000,
    "deferredrentcreditnoncurrent": 1649000,
    "leaseincentivepayablenoncurrent": 3051000,
    "deferredrevenuenoncurrent": 2971000,
    "liabilities": 34396000,
    "commonstockvalue": 28000,
    "additionalpaidincapitalcommonstock": 316775000,
    "accumulatedothercomprehensiveincomelossnetoftax": -2000,
    "retainedearningsaccumulateddeficit": -221620000,
    "stockholdersequity": -221620000,
    "liabilitiesandstockholdersequity": 129577000,
    "preferredstockparorstatedvaluepershare": 2,
    "preferredstocksharesauthorized": 5000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 200000000,
    "commonstocksharesissued": 28067402,
    "commonstocksharesoutstanding": 27941566,
    "revenuefromcontractwithcustomerincludingassessedtax": 8823000,
    "researchanddevelopmentexpense": 59042000,
    "generalandadministrativeexpense": 21392000,
    "operatingexpenses": 80434000,
    "operatingincomeloss": -71611000,
    "interestincomeexpensenonoperatingnet": 792000,
    "netincomeloss": -70819000,
    "netincomelossavailabletocommonstockholdersbasic": -70819000,
    "earningspersharebasicanddiluted": -2.79,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 25354,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": -2000,
    "othercomprehensiveincomelossnetoftax": -2000,
    "comprehensiveincomenetoftax": -70821000,
    "sharesoutstanding": 27941566,
    "stockissuedduringperiodvaluenewissues": 5736000,
    "stockissuedduringperiodsharesnewissues": 550000,
    "stockissuedduringperiodvalueemployeebenefitplan": 1430000,
    "stockissuedduringperiodsharesemployeebenefitplan": 182359,
    "stockissuedduringperiodvaluerestrictedstockawardgross": 15000,
    "stockissuedduringperiodsharesrestrictedstockawardgross": 525352,
    "stockrepurchasedduringperiodshares": 29882,
    "treasurystocksharesretired": 29882,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 7350000,
    "profitloss": -70819000,
    "depreciation": 2379000,
    "sharebasedcompensation": 3380000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 68000,
    "increasedecreaseinaccountsandotherreceivables": 2000000,
    "increasedecreaseinaccountsreceivable": 531000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 697000,
    "increasedecreaseinotheroperatingassets": 519000,
    "increasedecreaseinaccountspayable": 1773000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": 1976000,
    "increasedecreaseindeferredrevenue": 7881000,
    "increasedecreaseindeferredrentanddeferredleaseincentive": -380000,
    "netcashprovidedbyusedinoperatingactivities": -53655000,
    "paymentstoacquiremarketablesecurities": 124270000,
    "proceedsfrommaturityofmarketablesecurities": 68474000,
    "paymentstoacquirepropertyplantandequipment": 1342000,
    "netcashprovidedbyusedininvestingactivities": -57138000,
    "proceedsfromissuanceinitialpublicoffering": -193000,
    "proceedsfromissuanceofprivateplacement": 64210000,
    "proceedsfromissuanceofcommonstock": 1429000,
    "repaymentsoflongtermcapitalleaseobligations": 50000,
    "netcashprovidedbyusedinfinancingactivities": 71132000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -39661000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 58144000,
    "interestpaidnet": 4000,
    "capitalexpendituresincurredbutnotyetpaid": 262000,
    "sharesissuedpricepershare": 2.04,
    "propertyplantandequipmentusefullife": "P3Y",
    "propertyplantandequipmentestimatedusefullives": "Shorter of useful life or remaining lease term",
    "numberofoperatingsegments": 1,
    "cashandcashequivalentsfairvaluedisclosure": 57052000,
    "availableforsalesecuritiesdebtsecurities": 55862000,
    "assetsfairvaluedisclosure": 55862000,
    "cashandcashequivalentsamortizedcost": 57052000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 55864000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 2000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 4000,
    "cashequivalentsandmarketablesecuritiesamortizedcostbasis": 112916000,
    "cashequivalentsandmarketablesecuritiesaccumulatedgrossunrealizedgainsbeforetax": 2000,
    "cashequivalentsandmarketablesecuritiesaccumulatedgrossunrealizedlossbeforetax": 4000,
    "cashequivalentsandmarketablesecuritiesfairvaluedisclosure": 112914000,
    "debtsecuritiesavailableforsalecontinuousunrealizedlosspositionlessthan12months": 13400000,
    "debtsecuritiesavailableforsalecontinuousunrealizedlossposition12monthsorlonger": 3100000,
    "propertyplantandequipmentgross": 200000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 200000,
    "prepaidexpenses": 3668000,
    "prepaidsignonbonusessubjecttovestingprovisions": 147000,
    "interestreceivable": 176000,
    "otherassetscurrent": 74000,
    "accruedresearchanddevelopmentexpenses": 4082000,
    "employeerelatedliabilitiescurrent": 2928000,
    "accruedprofessionalfeescurrent": 196000,
    "capitalleaseobligationscurrent": 17000,
    "accruedrestrictedstockliabilitycurrent": 6000,
    "otherliabilitiescurrent": 38000,
    "capitalleasesfutureminimumpaymentsduecurrent": 100000,
    "capitalleasesfutureminimumpaymentsdueintwoyears": 100000,
    "convertiblepreferredstocktermsofconversion": "On the date of issuance, the estimated fair value of common stock into which the Preferred Stock was convertible was less than the effective conversion price of the Preferred Stock, and as such, there was no beneficial conversion feature at the commitment dates.",
    "numberofdirectorsstockholdersareentitledtoelect": 1,
    "preferredstockconversionpricepershare": 14,
    "minimumpercentageofshareholdersvoteorwrittenconsentrequiredforautomaticconversion": 0.65,
    "preferredstockdividendrateperdollaramount": 0.08,
    "minimumpercentageofoutstandingsharesofpreferredstockforliquidationpreference": 0.65,
    "commonstockvotingrights": "Each share of common stock entitles the holder to one vote on all matters submitted to a vote of the Company’s stockholders",
    "numberofcommonstockvotingrights": 1,
    "commonstockcapitalsharesreservedforfutureissuance": 465999,
    "sharesreservedforconversionofpreferredstockandfutureissuanceofcommonstock": 5156962,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y6M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 9.76,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 1400000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvaluevested": 8800000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 16000000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y6M25D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 42858,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 291789,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsrepurchasedinperiod": 29882,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 2.93,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 2.94,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsrepurchasedinperiodweightedaveragegrantdatefairvalue": 3.05,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 2962347,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1352306,
    "stockissuedduringperiodsharesstockoptionsexercised": 162861,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 250926,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 873748,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 11.57,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 14.6,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 7.49,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 12.3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 10.54,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P7Y11M23D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 5767895,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 2256315,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.012,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.776,
    "nonrefundableupfrontpaymentsreceived": 10000000,
    "researchdevelopmentandsalesarrangementaggregateamountreceivableuponachievementofmilestone": 2000000,
    "rangeoftieredroyaltiesonnetsales": "mid single-digit percentage to a low double-digit percentage",
    "revenuefromcontractwithcustomerexcludingassessedtax": 2500000,
    "cumulativecatchupadjustment": 500000,
    "deferredrevenuecurrentandnoncurrent": 10000000,
    "reimbursementpaymentrecieved": 1700000,
    "unbilledaccountsreceivablerelatedtoreimbursableresearchanddevelopmentcost": 500000,
    "accountsandnotesreceivablenet": 2000,
    "stockissuedduringperiodsharespurchaseofassets": 12500000000000,
    "stockissuedduringperiodvaluepurchaseofassets": 25500000,
    "clinicalandregulatorymilestonepayables": 37500000,
    "clinicalandregulatorymilestonespayableuponinitiationofphasetwoclinicaltrial": 2500000,
    "salesmilestone": 60000000,
    "acquisitioncosts": 100000,
    "lesseeoperatingleaseoptiontoextend": "The Company has the option to extend the term of the lease for an additional five-year period, at the market rate, by giving the landlord written notice of its election to exercise the extension at least nine months prior to the original expiration of the lease term.",
    "lesseeoperatingleaseliabilitypaymentsdue": 19462000,
    "leaseandrentalexpense": 1900000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 2354000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 2424000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 2497000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 2572000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 2649000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 6966000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationnondeductibleexpense": -0.0079,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.0257,
    "effectiveincometaxratereconciliationfederalorphandrugcredits": 0.0428,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.0614,
    "effectiveincometaxratereconciliationotherreconcilingitemspercent": 0.0047,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.3367,
    "deferredtaxassetsoperatinglosscarryforwards": 46603000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 6842000,
    "deferredtaxassetsorphandrugcreditcarryforwards": 3000000,
    "deferredtaxassetsgoodwillandintangibleassets": 6722000,
    "deferredtaxassetsdeferredincome": 1791000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 2240000,
    "deferredtaxassetsleaseincentive": 962000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsdeferredrent": 450000,
    "deferredtaxassetsgross": 68642000,
    "deferredtaxassetsvaluationallowance": 67427000,
    "deferredtaxassetsnet": 1215000,
    "deferredincometaxliabilities": 1215000,
    "operatinglosscarryforwardsvaluationallowance": 23800000,
    "operatinglosscarryforwards": 170200000,
    "operatinglosscarryforwardsexpirationyear": 2035,
    "operatinglosscarryforwardsindefinitely": 139700000,
    "taxcreditcarryforwardamount": 2800000,
    "taxcreditcarryforwardexpirationyear": 2040,
    "opentaxyear": "2016 2016 2017 2018 2019 2020",
    "definedcontributionplanname": "401(k)",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 3088183,
    "stockissuedduringperiodsharesissuedforservices": 142284
  },
  {
    "date": "2019-12-30",
    "symbol": "FULC",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2019-12-31",
    "documentfiscalyearfocus": 2019,
    "documentfiscalperiodfocus": "FY",
    "security12btitle": "Common stock, par value $0.001 per share",
    "tradingsymbol": "FULC",
    "securityexchangename": "NASDAQ",
    "entityregistrantname": "FULCRUM THERAPEUTICS, INC.",
    "entitycentralindexkey": 1680581,
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "entityshellcompany": "false",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityfilenumber": "001-38978",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "47-4839948",
    "entityaddressaddressline1": "26 Landsdowne Street",
    "entityaddresscityortown": "Cambridge",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2139,
    "cityareacode": 617,
    "localphonenumber": "651-8851",
    "documenttransitionreport": "false",
    "documentannualreport": "true",
    "entityvoluntaryfilers": "No",
    "entitywellknownseasonedissuer": "No",
    "cashandcashequivalentsatcarryingvalue": 96713000,
    "prepaidexpenseandotherassetscurrent": 3370000,
    "assetscurrent": 100083000,
    "propertyplantandequipmentnet": 9205000,
    "restrictedcashnoncurrent": 1092000,
    "otherassetsnoncurrent": 59000,
    "assets": 110439000,
    "accountspayablecurrent": 2186000,
    "accruedliabilitiesandothercurrentliabilities": 5496000,
    "leaseincentivepayablecurrent": 469000,
    "deferredrevenuecurrent": 3989000,
    "liabilitiescurrent": 12140000,
    "deferredrentcreditnoncurrent": 1559000,
    "leaseincentivepayablenoncurrent": 3521000,
    "deferredrevenuenoncurrent": 6011000,
    "otherliabilitiesnoncurrent": 55000,
    "liabilities": 23286000,
    "commonstockvalue": 23000,
    "additionalpaidincapitalcommonstock": 237931000,
    "retainedearningsaccumulateddeficit": -150801000,
    "stockholdersequity": -150801000,
    "liabilitiesandstockholdersequity": 110439000,
    "temporaryequityparorstatedvaluepershare": 0.001,
    "temporaryequitysharesoutstanding": 112500000,
    "preferredstockparorstatedvaluepershare": 2,
    "preferredstocksharesauthorized": 5000000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 200000000,
    "commonstocksharesissued": 23335514,
    "commonstocksharesoutstanding": 22654444,
    "researchanddevelopmentexpense": 71072000,
    "generalandadministrativeexpense": 13145000,
    "operatingexpenses": 84217000,
    "operatingincomeloss": -84217000,
    "interestincomeexpensenonoperatingnet": 1511000,
    "othernonoperatingincome": 29000,
    "netincomeloss": -82677000,
    "preferredstockdividendsincomestatementimpact": 7128000,
    "netincomelossavailabletocommonstockholdersbasic": -89805000,
    "earningspersharebasicanddiluted": -8.13,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 11046,
    "sharesoutstanding": 22654444,
    "temporaryequitystockissuedduringperiodvaluenewissues": 25466000,
    "temporaryequitystockissuedduringperiodsharesnewissues": 12500000,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": -165136000,
    "temporaryequitystockissuedduringperiodsharesconversionofconvertiblesecurities": 52500000,
    "temporaryequitystockissuedduringperiodvalueconversionofconvertiblesecurities": 105227000,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": -16071418,
    "stockissuedduringperiodvalueinitialpublicofferingnetofunderwritingdiscountscommissionsandofferingcosts": 63872000,
    "stockissuedduringperiodsharesinitialpublicofferingnetofunderwritingdiscountscommissionsandofferingcosts": 4500000,
    "stockissuedduringperiodvaluenewissues": 268000,
    "stockissuedduringperiodsharesnewissues": 495073,
    "stockrepurchasedduringperiodshares": 61450,
    "treasurystocksharesretired": 128474,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 4224000,
    "sharesissuedpricepershare": 2.04,
    "profitloss": -82677000,
    "depreciation": 2053000,
    "sharebasedcompensation": 1977000,
    "researchanddevelopmentinprocess": 25591000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 2459000,
    "increasedecreaseinotheroperatingassets": 20000,
    "increasedecreaseinaccountspayable": 803000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": 2949000,
    "increasedecreaseindeferredrevenue": 10000000,
    "increasedecreaseindeferredrentanddeferredleaseincentive": 53000,
    "netcashprovidedbyusedinoperatingactivities": -39483000,
    "paymentstoacquirepropertyplantandequipment": 853000,
    "paymentstoacquireintangibleassets": 91000,
    "netcashprovidedbyusedininvestingactivities": -944000,
    "proceedsfromrepurchaseofredeemablepreferredstock": -34000,
    "proceedsfromissuanceinitialpublicoffering": 64173000,
    "repaymentsoflongtermcapitalleaseobligations": 45000,
    "proceedsfromissuanceofcommonstock": 249000,
    "netcashprovidedbyusedinfinancingactivities": 64343000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 23916000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 97805000,
    "interestpaidnet": 7000,
    "noncashorpartnoncashacquisitionintangibleassetsacquired1": 25500000,
    "conversionofconvertiblepreferredstockintocommonstock": 165136000,
    "capitalexpendituresincurredbutnotyetpaid": 34000,
    "publicofferingcostsunpaid": 301000,
    "propertyplantandequipmentusefullife": "P3Y",
    "propertyplantandequipmentestimatedusefullives": "Shorter of useful life or remaining lease term",
    "numberofoperatingsegments": 1,
    "cashandcashequivalentsfairvaluedisclosure": 96713000,
    "propertyplantandequipmentgross": 200000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 100000,
    "prepaidexpenses": 2796000,
    "prepaidsignonbonusessubjecttovestingprovisions": 179000,
    "interestreceivable": 111000,
    "otherassetscurrent": 284000,
    "accruedresearchanddevelopmentexpenses": 2250000,
    "employeerelatedliabilitiescurrent": 2239000,
    "accruedprofessionalfeescurrent": 891000,
    "capitalleaseobligationscurrent": 50000,
    "accruedrestrictedstockliabilitycurrent": 17000,
    "otherliabilitiescurrent": 49000,
    "capitalleasesfutureminimumpaymentsduecurrent": 100000,
    "capitalleasesfutureminimumpaymentsdueintwoyears": 100000,
    "convertiblepreferredstocktermsofconversion": "On the date of issuance, the estimated fair value of common stock into which the Preferred Stock was convertible was less than the effective conversion price of the Preferred Stock, and as such, there was no beneficial conversion feature at the commitment dates.",
    "numberofdirectorsstockholdersareentitledtoelect": 1,
    "preferredstockconversionpricepershare": 14,
    "minimumpercentageofshareholdersvoteorwrittenconsentrequiredforautomaticconversion": 0.65,
    "preferredstockdividendrateperdollaramount": 0.08,
    "minimumpercentageofoutstandingsharesofpreferredstockforliquidationpreference": 0.65,
    "commonstockvotingrights": "Each share of common stock entitles the holder to one vote on all matters submitted to a vote of the Company’s stockholders",
    "numberofcommonstockvotingrights": 1,
    "commonstockcapitalsharesreservedforfutureissuance": 1866694,
    "sharesreservedforconversionofpreferredstockandfutureissuanceofcommonstock": 4142664,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P9Y1M13D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 6.97,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 112142,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvaluevested": 4800000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 12200000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y9M10D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 334647,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsrepurchasedinperiod": 61450,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 2.94,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 2.94,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsrepurchasedinperiodweightedaveragegrantdatefairvalue": 3.02,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 2023828,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1561594,
    "stockissuedduringperiodsharesstockoptionsexercised": 33782,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 11875,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 310423,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 9.31,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 9.98,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 7.49,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 9.58,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 7.84,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P8Y11M8D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 14840035,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 2730209,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.023,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.809,
    "nonrefundableupfrontpaymentsreceived": 10000000,
    "researchdevelopmentandsalesarrangementaggregateamountreceivableuponachievementofmilestone": 217500000,
    "rangeoftieredroyaltiesonnetsales": "mid single-digit percentage to a low double-digit percentage",
    "deferredrevenuecurrentandnoncurrent": 10000000,
    "stockissuedduringperiodsharespurchaseofassets": 12500000000000,
    "stockissuedduringperiodvaluepurchaseofassets": 25500000,
    "clinicalandregulatorymilestonepayables": 37500000,
    "clinicalandregulatorymilestonespayableuponinitiationofphasetwoclinicaltrial": 2500000,
    "salesmilestone": 60000000,
    "acquisitioncosts": 100000,
    "clinicalandregulatorymilestonedueuponinitiationofphasetwoclinicaltrialachievedandpaid": 2500000,
    "clinicalandregulatorymilestonesdueuponinitiationofphasetwoclinicaltrialrecordedasexpense": 2500000,
    "leaseandrentalexpense": 1900000,
    "lesseeoperatingleaseoptiontoextend": "The Company has the option to extend the term of the lease for an additional five-year period, at the market rate, by giving the landlord written notice of its election to exercise the extension at least nine months prior to the original expiration of the lease term.",
    "lesseeoperatingleaseliabilitypaymentsdue": 21747000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 2285000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 2354000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 2424000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 2497000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 2572000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 9615000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationnondeductibleexpense": -0.0067,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.0206,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.0616,
    "effectiveincometaxratereconciliationotherreconcilingitemspercent": 0.0048,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.2903,
    "deferredtaxassetsoperatinglosscarryforwards": 30444000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 4658000,
    "deferredtaxassetsgoodwillandintangibleassets": 7235000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 1149000,
    "deferredtaxassetsleaseincentive": 1090000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsdeferredrent": 426000,
    "deferredtaxassetsgross": 45002000,
    "deferredtaxassetsvaluationallowance": 43586000,
    "deferredtaxassetsnet": 1416000,
    "deferredincometaxliabilities": 1416000,
    "operatinglosscarryforwards": 111100000,
    "operatinglosscarryforwardsexpirationyear": 2035,
    "operatinglosscarryforwardsindefinitely": 80600000,
    "taxcreditcarryforwardamount": 2400000,
    "taxcreditcarryforwardexpirationyear": 2030,
    "opentaxyear": "2016 2016 2017 2018 2019",
    "definedcontributionplanplanname": "401(k)",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 2704898,
    "relatedpartytransactionexpensesfromtransactionswithrelatedparty": 100000,
    "stockissuedduringperiodsharesissuedforservices": 142284
  }
]